Zolpidem
(NYVVVBWEVRSKIU-LREBCSMRSA-N)
Structure
- SMILES
- O[C@H]([C@H](C(=O)O)O)C(=O)O.Cc1ccc(cc1)c1nc2n(c1CC(=O)N(C)C)cc(cc2)C
- Molecular Formula:
- C23H27N3O7
- Molecular Weight:
- 457.476
- Log P:
- 1.1262
- Hydrogen Bond Acceptor:
- 10
- Hydrogen Bond Donor:
- 4
- TPSA:
- 152.67
- CAS Number(s):
- 99294-93-6
Synonym(s)
1.
Zolpidem
2.
Ambien
3.
Amsic
4.
Bikalm
5.
Dalparan
6.
N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2a)pyridine-3-acetamide hemitartrate
7.
SL 80.0750
8.
SL-800750-23-N
9.
Stilnoct
10.
Stilnox
11.
Zodormdura
12.
Zoldem
13.
Zolirin
14.
Zolpi-Lich
15.
Zolpidem 1A Pharma
16.
Zolpidem AbZ
17.
Zolpidem Hemitartrate
18.
Zolpidem Tartrate
19.
Zolpimist
20.
Zolpinox
21.
SL 800750 23 N
22.
Zolpi Lich
External Link(s)
| MeSH | D000077334 |
| PubChem Compound | 57487 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 447 Canada Vigilance: 15 | Canada Vigilance US FAERS | |
| 2 | Incorrect dose administered | FAERS: 96 | US FAERS | |
| 3 | Inappropriate schedule of drug administration | FAERS: 52 | US FAERS | |
| 4 | Somnolence | FAERS: 45 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Product taste abnormal | FAERS: 34 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 6 | Incorrect route of drug administration | FAERS: 33 | US FAERS | |
| 7 | Product solubility abnormal | FAERS: 32 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 8 | Drug prescribing error | FAERS: 28 | US FAERS | |
| 9 | Fatigue | FAERS: 22 | US FAERS | |
| 10 | Feeling abnormal | FAERS: 17 | US FAERS | |
| 11 | Wrong technique in drug usage process | FAERS: 17 | US FAERS | |
| 12 | Drug effect delayed | FAERS: 15 | US FAERS | |
| 13 | Headache | FAERS: 15 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Nausea | FAERS: 12 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 15 | Dizziness | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 16 | Dysgeusia | FAERS: 8 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 17 | Drug effect incomplete | FAERS: 7 | US FAERS | |
| 18 | Product blister packaging issue | FAERS: 6 | US FAERS | |
| 19 | Extra dose administered | FAERS: 5 | US FAERS | |
| 20 | Incorrect drug dosage form administered | FAERS: 5 | US FAERS | |
| 21 | Poor quality sleep | FAERS: 5 | US FAERS | |
| 22 | Somnambulism | FAERS: 5 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 23 | Drug dispensing error | FAERS: 4 | US FAERS | |
| 24 | Product packaging issue | FAERS: 4 | US FAERS | |
| 25 | Product quality issue | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 26 | Abdominal discomfort | FAERS: 3 | US FAERS | |
| 27 | Agitation | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 28 | Anxiety | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 29 | Intentional drug misuse | FAERS: 3 | US FAERS | |
| 30 | Product physical issue | FAERS: 3 | US FAERS | |
| 31 | Unevaluable event | FAERS: 3 | US FAERS | |
| 32 | Vomiting | FAERS: 3 | US FAERS | |
| 33 | Drug ineffective for unapproved indication | FAERS: 2 | US FAERS | |
| 34 | Glossitis | FAERS: 2 | US FAERS | |
| 35 | Initial insomnia | FAERS: 2 | US FAERS | |
| 36 | Memory impairment | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 37 | Middle insomnia | FAERS: 2 | US FAERS | |
| 38 | Oral pain | FAERS: 2 | US FAERS | |
| 39 | Palpitations | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 40 | Therapeutic response delayed | FAERS: 2 | US FAERS | |
| 41 | Wrong technique in product usage process | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 42 | Activities of daily living impaired | FAERS: 1 | US FAERS | |
| 43 | Amnesia | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 44 | Aphthous Stomatitis | FAERS: 1 | US FAERS | |
| 45 | Application site ulcer | FAERS: 1 | US FAERS | |
| 46 | Burning sensation | FAERS: 1 | US FAERS | |
| 47 | Cardiac Arrest | FAERS: 1 | US FAERS | |
| 48 | Chills | FAERS: 1 | US FAERS | |
| 49 | Depressed mood | FAERS: 1 | US FAERS | |
| 50 | Disorientation | FAERS: 1 | US FAERS | |
| 51 | Drug abuse | FAERS: 1 | US FAERS | |
| 52 | Expired drug administered | FAERS: 1 | US FAERS | |
| 53 | Eyelid irritation | FAERS: 1 | US FAERS | |
| 54 | Flushing | FAERS: 1 | US FAERS | |
| 55 | Intentional misuse | FAERS: 1 | US FAERS | |
| 56 | Lethargy | FAERS: 1 | US FAERS | |
| 57 | Malaise | FAERS: 1 | US FAERS | |
| 58 | Medication residue present | FAERS: 1 | US FAERS | |
| 59 | Mood swings | FAERS: 1 | US FAERS | |
| 60 | Nervousness | FAERS: 1 | US FAERS | |
| 61 | Neuralgia | FAERS: 1 | US FAERS | |
| 62 | Overdose | FAERS: 1 | US FAERS | |
| 63 | Potentiating drug interaction | FAERS: 1 | US FAERS | |
| 64 | Product packaging quantity issue | FAERS: 1 | US FAERS | |
| 65 | Restless Legs Syndrome | FAERS: 1 | US FAERS | |
| 66 | Restlessness | FAERS: 1 | US FAERS | |
| 67 | Sinusitis | FAERS: 1 | US FAERS | |
| 68 | Sleep Talking | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 69 | Sleep-related eating disorder | FAERS: 1 | US FAERS | |
| 70 | Sluggishness | FAERS: 1 | US FAERS | |
| 71 | Stress | FAERS: 1 | US FAERS | |
| 72 | Therapeutic product ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 73 | Thermal burn | FAERS: 1 | US FAERS | |
| 74 | Throat irritation | FAERS: 1 | US FAERS | |
| 75 | Tongue eruption | FAERS: 1 | US FAERS | |
| 76 | Tremor | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 77 | Abdominal Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 78 | Arthralgia | Canada Vigilance: 2 | Canada Vigilance | |
| 79 | Arthritis | Canada Vigilance: 1 | Canada Vigilance | |
| 80 | Completed Suicide | Canada Vigilance: 1 | Canada Vigilance | |
| 81 | Diplopia | Canada Vigilance: 1 | Canada Vigilance | |
| 82 | Frustration tolerance decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 83 | Gastritis | Canada Vigilance: 1 | Canada Vigilance | |
| 84 | Hypersensitivity | Canada Vigilance: 1 | Canada Vigilance | |
| 85 | Impaired work ability | Canada Vigilance: 1 | Canada Vigilance | |
| 86 | Incorrect product administration duration | Canada Vigilance: 1 | Canada Vigilance | |
| 87 | Incorrect route of product administration | Canada Vigilance: 1 | Canada Vigilance | |
| 88 | Intentional product use issue | Canada Vigilance: 1 | Canada Vigilance | |
| 89 | Product administration error | Canada Vigilance: 1 | Canada Vigilance | |
| 90 | Pruritus | Canada Vigilance: 2 | Canada Vigilance | |
| 91 | Suicide attempt | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.